MedTrace Logo

Salivary Transcriptome Biomarkers for Early Diabetes Detection

NCT02673762 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 180

Last updated 2018-04-12

No results posted yet for this study

Summary

A PRoBE design study will be used to obtain saliva from patients before undergoing blood study evaluation for screening at risk patients for the presence of undiagnosed pre-diabetes of type II diabetes. Pre-specified saliva biomarkers will be evaluated along with multi-marker models for their discriminatory value for distinguishing patients with normal glucose metabolism from those with disease. Appropriate housekeeping genes will also be incorporated to allow for the measurement of relative gene expression.

Conditions

Sponsors & Collaborators

  • PeriRx

    lead INDUSTRY

Principal Investigators

  • Jack L Martin, MD · San Antonio Endovascular and Heart Institute

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-01-31
Primary Completion
2018-12-31
Completion
2019-02-28

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02673762 on ClinicalTrials.gov